Nine checks that separate a supplier worth a purchase order from one worth avoiding — written for researchers and procurement officers across the GCC.

Most guidance on choosing a research peptide supplier collapses into a single instruction: ask for a Certificate of Analysis. That is good advice and nowhere near sufficient. A COA is a document, and documents can be generic, outdated, borrowed or simply unrelated to the vial in front of you. What follows is the fuller list — the checks that actually distinguish a supplier worth a standing order.

1. Is the Certificate Specific to the Batch You Are Buying?

This is the check that matters most and is skipped most often. A supplier can hold a perfectly genuine test report for a batch produced eighteen months ago and show it to every customer since.

Ask which lot number your vial comes from, and whether the certificate you have been shown corresponds to that lot. A supplier who cannot connect a specific vial to a specific test is showing you a marketing asset, not evidence.

2. Who Performed the Test?

In-house testing is not worthless, but it is self-reported. Independent third-party analysis carries the weight because the laboratory performing it has no stake in the result.

Look for the testing laboratory to be named on the certificate. An unattributed report is difficult to take seriously.

3. Does the Documentation Cover Identity as Well as Purity?

Chromatography answers “how much of this vial is one dominant substance”. Mass spectrometry answers “and is that substance the one on the label”.

They are different questions. A high purity figure on a mislabelled compound is a high purity figure for the wrong thing. A complete package addresses both.

4. Can You See the Chromatogram, or Only the Percentage?

A summary figure asks you to trust a transcription. The trace itself shows the shape of the result: whether the main peak is clean, whether there are unexpected companions, whether the baseline is sensible.

Suppliers confident in their material tend to publish the trace. Suppliers who publish only a number have made a choice about how much scrutiny they want.

5. How Does the Compound Reach You?

Two questions, and the answers should be specific rather than reassuring.

• Where is the stock held? Regional stock is a domestic delivery. Overseas stock is an import, with everything that implies for delay and heat exposure.
• How long is transit? Days is a normal answer. “It depends on customs” is an answer that tells you the supplier does not control this part of the process.

6. Does the Supplier Sell the Add-Ons the Product Requires?

A lyophilised peptide cannot be used without bacteriostatic water. A supplier who sells vials but not the water to reconstitute them either has not thought about what happens after delivery, or is leaving the customer to solve it.

It is a small signal, and a reliable one.

7. How Does the Supplier Talk About Its Own Products?

This is the fastest read available, and it takes about ninety seconds on a product page.

A supplier operating properly describes molecular weight, sequence, purity, presentation and handling. A supplier operating improperly describes results, protocols, dosing, before-and-after outcomes, or what a compound will do for a person.

The second kind is not merely distasteful — under the UAE’s medical products framework, promoting unauthorised compounds for human use is a regulatory violation. In July 2026 the Emirates Drug Establishment acted against 71 sources selling unapproved peptide products and referred 14 social media influencers over the online promotion of medicines. A supplier marketing that way is carrying a risk, and any customer depending on that supplier for continuity of supply is carrying it too.

8. Can a Human Be Reached, Quickly?

Procurement problems are time-sensitive and boring: a lot number query, a stock check before a purchase order closes, a delivery that needs redirecting. A named contact method with a same-day response is worth a surprising amount. A contact form that disappears into an inbox is not.

Check the stated support hours and whether they overlap with your working day. A supplier in a distant time zone answers tomorrow, every time.

9. What Happens When Something Goes Wrong?

Ask before you need to know. Is there a documented policy for a lost, damaged or seized shipment? Does it depend on whether the order was insured? Is the position written down somewhere you can read it, or does it depend on the mood of the reply?

A supplier with a clear, published position on failure has thought about failure. That is a better signal than a supplier who has only ever described success.

Using the List

Not every check will apply to every order, and no supplier will score perfectly on all nine. The purpose is not to find a flawless vendor but to know precisely where the gaps are before a purchase order goes out, rather than discovering them when a result looks wrong and the batch is already consumed.

If you are running a formal evaluation, the checks divide neatly: items 1–4 are analytical, 5–6 are logistical, and 7–9 are operational. Weakness in the analytical group is disqualifying. Weakness in the other two is a cost you can decide whether to accept.

This list is published by a supplier, which you should hold against it. So here are SHLabz’s own answers first, in the same order — check them, then put the identical nine questions to everyone else on your shortlist and compare what comes back.

• 1–4, analytical. Certificates are tied to the lot you receive, not a representative batch, and name the testing laboratory.
• 5–6, logistical. Stock sits inside the region, so delivery is measured in days. Bacteriostatic water is stocked alongside the compounds and offered at checkout.
• 7–9, operational. Listings carry molecular detail and no human-use claims; support answers Monday to Friday, 9:00 AM–6:00 PM UAE time; and the position on lost or seized shipments is written into the published shipping policy rather than decided case by case.

Everything is supplied strictly for laboratory research use.

References

• Federal Decree-Law No. (38) of 2024 Governing Medical Products, Pharmacists and Pharmaceutical Establishments — UAE Legislation portal.
• UAE cracks down on unapproved peptide weight-loss drugs: 71 sources and 14 influencers face action — Gulf News, July 2026.

The list is more useful with something to apply it to: our certificates and catalogue are both open to inspection.

This article is provided for general research and educational purposes only. All SHLabz products are sold strictly for laboratory research use and are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. Nothing in this article constitutes medical advice. Always consult a qualified professional and comply with applicable local regulations regarding the handling and use of research compounds.